Clear leader
18 companies value 78 bn revenue 9.7 bn margin 9.2% free cash flow 2.8 bn avg. score 3.6
VEEV holds 65.8% of the group's value, 6.7x the runner-up
| Rank | Ticker | Company | Share | Value | Revenue | Margin | FCF | 5 years | FCF/px | Yield | What it does · why it is here |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | VEEV | Veeva Systems United States · score 6.1 | 66% | 51 bn | 3.5 bn | 29.3% | 1.7 bn | 3.2% | — | Cloud software for the life sciences industry · The pharma industry's standard system for clinical and commercial data | |
| 2 | HQY | HealthEquity United States · score 6.4 | 10% | 7.7 bn | 1.4 bn | 17.4% | 0.5 bn | 6.3% | — | Administration of tax-advantaged health accounts · Largest US administrator of health savings accounts (HSA) | |
| 3 | DOCS | Doximity United States · score 6.6 | 7% | 5.6 bn | 0.7 bn | 25.5% | 0.3 bn | 5.5% | — | Professional network and marketing for physicians · The social network for US physicians; high-margin pharma advertising | |
| 4 | WAY | Waystar Holding Corp. United States · score 5.1 | 7% | 5.4 bn | 1.2 bn | 11.2% | 0.3 bn | 4.6% | — | AI-powered software for healthcare payments · Utah — revenue of $1.2bn | |
| 5 | HTFL | Heartflow, Inc. United States · score 0.1 | 6% | 4.4 bn | 0.2 bn | -55.8% | -0.1 bn | -1.3% | — | AI software for noninvasive coronary artery disease diagnosis · California — revenue of $212m | |
| 6 | HSTM | HEALTHSTREAM INC United States · score 7.0 | 1% | 1.0 bn | 0.3 bn | 6.6% | 0.1 bn | 7.2% | 0.4% | Training and workforce management software for healthcare · Tennessee — revenue of $321m | |
| 7 | PHR | Phreesia, Inc. United States · score 6.6 | 1% | 0.7 bn | 0.5 bn | 2.1% | 0.1 bn | 11.5% | — | Software, payments and engagement for healthcare access and cost · Delaware — revenue of $508m | |
| 8 | WEAV | Weave Communications, Inc. United States · score 2.5 | 1% | 0.6 bn | 0.3 bn | -8.0% | 0.0 bn | 2.4% | — | AI-powered communications and payments for small practices · Utah — revenue of $258m | |
| 9 | NRC | NRC HEALTH United States · score 6.3 | 1% | 0.5 bn | 0.1 bn | 4.2% | 0.0 bn | 4.8% | 2.8% | Patient experience research and analytics for hospitals · Nebraska — revenue of $140m | |
| 10 | CTEV | Claritev Corp United States · score 0.0 | 1% | 0.4 bn | 1.0 bn | -28.5% | -0.0 bn | -4.8% | — | Technology and AI for healthcare claims management, for 45 years · Virginia — revenue of $995m | |
| 11 | SPOK | Spok Holdings, Inc United States · score 6.3 | 0% | 0.2 bn | 0.1 bn | 9.0% | 0.0 bn | 11.6% | 12.5% | Clinical communications for hospitals: software and paging services · Texas — revenue of $136m | |
| 12 | HCAT | Health Catalyst, Inc. United States · score 3.2 | 0% | 0.1 bn | 0.3 bn | -90.6% | 0.0 bn | 21.0% | — | Data and analytics for healthcare organizations · Utah — revenue of $292m | |
| 13 | CCLD | CareCloud, Inc. United States · score 7.7 | 0% | 0.1 bn | 0.1 bn | 6.2% | 0.0 bn | 29.8% | — | Technology and generative AI for the healthcare revenue cycle · New Jersey — revenue of $129m | |
| 14 | ONMD | OneMedNet Corp United Kingdom · score 0.2 | 0% | 0.0 bn | 0.0 bn | — | -0.0 bn | -25.2% | — | Clinical imaging innovation and regulatory real-world data · United Kingdom — revenue of $1m | |
| 15 | AIFF | FIREFLY NEUROSCIENCE, INC. United States · score 0.0 | 0% | 0.0 bn | 0.0 bn | -506.2% | -0.0 bn | -44.5% | — | Artificial intelligence applied to precision neuroscience · New York — revenue of $2m | |
| 16 | AMST | Amesite Inc. United States · score 0.0 | 0% | 0.0 bn | 0.0 bn | -848.2% | 0.0 bn | -41.4% | — | Artificial intelligence for post-acute care · Michigan | |
| 17 | KALA | KALA BIO, Inc. United States · score 0.0 | 0% | 0.0 bn | 0.0 bn | — | -0.0 bn | -536.8% | — | On-premises AI platform for biotech, formerly ocular surface therapies · Massachusetts | |
| 18 | HCTI | Healthcare Triangle, Inc. United States · score 0.8 | — | — | 0.0 bn | -66.3% | -0.0 bn | — | — | Health IT: cloud, data and electronic health records · California — revenue of $26m |
Other industries in the same sector
- Sector overview
- Large-cap pharmaceuticals 9 companies
- Biotechnology 57 companies
- European pharmaceuticals 5 companies
- Lab tools and consumables 37 companies
- Health insurance and services 17 companies
- Medical devices 87 companies
- Specialty pharmaceuticals 77 companies
- Pharmaceutical distribution 7 companies
- Clinical-stage pharmaceuticals 251 companies
- Robotic surgery and advanced medtech 9 companies
- Hospitals 23 companies
- Emerging biotech 5 companies
and 22 industries more
- Molecular testing and advanced diagnostics 42 companies
- Vaccines and mRNA 14 companies
- Clinical-stage biotech 200 companies
- Generics and biosimilars 10 companies
- Animal health 7 companies
- Contract research (CRO) 10 companies
- Consumer health (OTC) 4 companies
- Rehabilitation and home care 15 companies
- Genomics and sequencing 9 companies
- Structural heart 8 companies
- Ophthalmology 12 companies
- Medical imaging and hospital equipment 16 companies
- Diagnostic labs 6 companies
- Medical and dental supply distribution 3 companies
- Diabetes monitoring 9 companies
- Pharmaceutical royalties 5 companies
- Respiratory and sleep therapy 9 companies
- Orthopedic implants 17 companies
- Dialysis 3 companies
- Telehealth and digital health 12 companies
- Dental 4 companies
- Medical and recreational cannabis 16 companies
What this is. A catalogue, not a guide. Every industry with stocks listed on the NYSE or NASDAQ, the companies contending for its leadership, what each one does according to its own annual report, and the balance sheet it filed with the SEC.
The score runs from 0 to 10 and compares each company with every other one in the almanac on cash generation, profitability, debt, dividends and consistency over the last five years. The higher it is, the better the company fares in that comparison. Curious how much each part weighs? Ask at the bottom of the page.
The score runs from 0 to 10 and compares each company with every other one in the almanac on cash generation, profitability, debt, dividends and consistency over the last five years. The higher it is, the better the company fares in that comparison. Curious how much each part weighs? Ask at the bottom of the page.